HomeAI · summaries
Storia in 2 fonti
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
- ·
ilsole24ore.com
Eli Lilly batte le attese nel primo trimestre e alza le stime 2026
Il gruppo prevede ora ricavi 2026 fino a 85 miliardi di dollari (da 83 miliardi) e un utile per azione rettificato compreso tra 35,50 e 37 dollari